Epidemiology of CRE and MRSA transmission: patient and organism factors
CRE 和 MRSA 传播的流行病学:患者和机体因素
基本信息
- 批准号:9330060
- 负责人:
- 金额:$ 58.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-10 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdherenceAdverse effectsAntibiotic ResistanceBacteriaBiological MarkersCaringCenters for Disease Control and Prevention (U.S.)CharacteristicsCohort StudiesComorbidityDesiccationDiabetes MellitusEpidemiologyFrequenciesFundingFutureGeographic LocationsGeographyGrantHIVHandHealth PersonnelIndividualInfectionInterventionKnowledgeLeadMechanical ventilationMethodologyMicrobial BiofilmsMicrobiologyMolecularMolecular EpidemiologyMorbidity - disease rateOrganismOutcomePatient CarePatient riskPatient-Focused OutcomesPatientsPropertyPublic HealthPublishingResearchResearch PersonnelResistanceRisk FactorsSerious Adverse EventSeverity of illnessSiteSpecimenSurfaceTestingUnited StatesVisitWorkbacterial resistancecarbapenem-resistant Enterobacteriaceaecost effectivedisorder preventioneffective interventionexperiencegenome sequencinghigh riskinnovationmethicillin resistant Staphylococcus aureusmortalitynovelpathogenpotential biomarkerpreventpsychological symptompublic health relevancetransmission processwhole genomewound
项目摘要
DESCRIPTION (provided by applicant):Carbapenem-resistant Enterobacteriaceae (CRE) and methicillin-resistant Staphylococcus aureus (MRSA) increase patient morbidity and mortality. CRE are emerging pathogens with a predilection for ICU patients. MRSA also is extremely prevalent, leading to a large number of patients in the United States being placed on contact precautions for MRSA. Contact precautions prevent the spread of antibiotic-resistant bacteria in the acute-care setting. However, contact precautions may also have adverse effects, including a decreased frequency of healthcare worker visits, increased psychological symptoms of patients, and potentially more serious adverse events. What is not known is if certain patients are more likely to transmit antibiotic-resistant bacteria to healthcare workers and subsequent patients, and if so, what characteristics identify these patients. In addition, what is not known is which healthcare worker-patient interactions lead to greater transmission and which bacterial-specific factors lead to increased transmission. The overall objective of this proposal is to explore factor associated with transmission of these bacteria and potential biomarkers to help determine which patients with CRE and MRSA should be placed on contact precautions, which may need enhanced precautions, and which may not need contact precautions. The proposed research is feasible because we have experience and have published using all of the methodologies proposed. Our hypothesis is that certain patient characteristics and certain healthcare worker-patient interactions lead to higher transmission and that the individual risk factors identified wil be unique for CRE and MRSA. We plan to test our central hypothesis and, thereby, accomplish the objective of this application by pursuing the following three specific aims: Aims 1 and 2: We will perform a multi-site, diverse geographic region cohort study to determine which patient risk factors and healthcare worker-patient interactions lead to greater transmission of CRE (aim 1) and MRSA (aim 2). Aim 3: We will perform whole genome sequencing on stored specimens obtained in aims 1 and 2 for high- transmission bacteria and low-transmission bacteria to determine molecular properties of the bacteria that result in observed differences in transmission. The significance of the proposed work is that it will lead to greater understanding of the factors associated with transmission of these bacteria, identifying high risk activities and
provide biomarkers to help determine which patients with CRE and MRSA should be placed on contact precautions, which may need enhanced precautions, and which may not need contact precautions. This proposal is innovative for the following reasons: a) It explores the novel concept of "superspreaders" of antibiotic-resistant bacteria, which has been suggested previously, but never studied in depth; b) The surrogate outcome of culturing healthcare workers hands and gloves upon room exit greatly increases the power of the study and is a near-perfect surrogate outcome for patient transmission; and c) This outcome choice allows the study to be done in a cost-effective manner on a smaller scale.
描述(由申请人提供):耐碳青霉烯类肠杆菌科(CRE)和耐甲氧西林金黄色葡萄球菌(MRSA)会增加患者的发病率和死亡率。CRE是一种新出现的病原体,易感染ICU患者。MRSA也非常普遍,导致美国大量患者被列入MRSA接触预防措施。接触预防措施可防止耐抗生素细菌在急性护理环境中传播。然而,接触预防措施也可能产生不利影响,包括医护人员就诊频率减少,患者心理症状增加,以及可能发生更严重的不良事件。目前尚不清楚的是,某些患者是否更有可能将抗药性细菌传播给医护人员和随后的患者,如果是这样,这些患者的特征是什么。此外,尚不清楚哪些医护人员与患者之间的互动会导致更大的传播,以及哪些细菌特有的因素会导致更多的传播。这项建议的总体目标是探索与这些细菌传播相关的因素和潜在的生物标志物,以帮助确定哪些CRE和MRSA患者应该采取接触预防措施,哪些可能需要加强预防措施,哪些可能不需要接触预防措施。建议的研究是可行的,因为我们有经验,并使用所有建议的方法发表了报告。我们的假设是,特定的患者特征和特定的医护人员与患者之间的互动会导致更高的传播率,并且所确定的个体风险因素对于CRE和MRSA是独一无二的。我们计划测试我们的中心假设,从而通过追求以下三个具体目标来实现这项应用的目标:目标1和目标2:我们将进行一项多地点、不同地理区域的队列研究,以确定哪些患者风险因素和医护人员与患者的互动导致CRE(目标1)和MRSA(目标2)的更大传播。目的3:我们将对AIMS 1和AIMS 2中获得的高传播菌和低传播菌的存储样本进行全基因组测序,以确定导致观察到的传播差异的细菌的分子特性。拟议工作的意义在于,它将使人们更好地了解与这些细菌传播有关的因素,识别高风险活动和
提供生物标志物,帮助确定哪些CRE和MRSA患者应采取接触预防措施,哪些可能需要加强预防措施,哪些可能不需要接触预防措施。这一建议具有创新性,原因如下:a)它探索了抗生素耐药细菌“超级传播者”的新概念,这一概念以前曾被提出过,但从未进行过深入研究;b)在离开房间时培养医护人员的手和手套的替代结果极大地增加了研究的力量,是患者传播的近乎完美的替代结果;以及c)这种结果选择使研究能够以成本效益高的方式在较小的规模上完成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY D HARRIS其他文献
ANTHONY D HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY D HARRIS', 18)}}的其他基金
Targeted Contact Precaution Use to Prevent MRSA Transmission
使用有针对性的接触预防措施来防止 MRSA 传播
- 批准号:
10178338 - 财政年份:2021
- 资助金额:
$ 58.04万 - 项目类别:
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
预防中心计划:保护患者免受感染、抗生素耐药性和其他不良事件的影响
- 批准号:
10466723 - 财政年份:2021
- 资助金额:
$ 58.04万 - 项目类别:
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
预防中心计划:保护患者免受感染、抗生素耐药性和其他不良事件的影响
- 批准号:
10403419 - 财政年份:2021
- 资助金额:
$ 58.04万 - 项目类别:
Targeted Contact Precaution Use to Prevent MRSA Transmission
使用有针对性的接触预防措施来防止 MRSA 传播
- 批准号:
10689825 - 财政年份:2021
- 资助金额:
$ 58.04万 - 项目类别:
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance andOther Adverse Events
预防中心计划:保护患者免受感染、抗生素耐药性和其他不良事件的影响
- 批准号:
10650204 - 财政年份:2021
- 资助金额:
$ 58.04万 - 项目类别:
Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies
预防医疗相关感染 (HAI) 的中心;
- 批准号:
9753064 - 财政年份:2018
- 资助金额:
$ 58.04万 - 项目类别:
Use of electronic data to improve risk adjustment for antibiotic utilization metrics
使用电子数据改进抗生素使用指标的风险调整
- 批准号:
9981718 - 财政年份:2018
- 资助金额:
$ 58.04万 - 项目类别:
Use of electronic data to improve risk adjustment for antibiotic utilization metrics
使用电子数据改进抗生素使用指标的风险调整
- 批准号:
9574676 - 财政年份:2018
- 资助金额:
$ 58.04万 - 项目类别:
Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies
预防医疗相关感染 (HAI) 的中心;
- 批准号:
10199880 - 财政年份:2018
- 资助金额:
$ 58.04万 - 项目类别:
Epidemiology of CRE and MRSA transmission: patient and organism factors
CRE 和 MRSA 传播的流行病学:患者和机体因素
- 批准号:
9986208 - 财政年份:2016
- 资助金额:
$ 58.04万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 58.04万 - 项目类别:
Fellowship Programs